Uterine Cancer Diagnostic Testing Market: Endometrial Biopsy Remains Sought-After Among End-Users
Growing women geriatric demography coupled with ever increasing healthcare expenditure has impelled uterine cancer diagnostic testing market. The uterine cancer diagnostic testing comprises of endometrial biopsy, pelvic examination, dilation and curettage (D&C), transvaginal ultrasound, computed tomography (CT) scan and magnetic resonance imaging (MRI). Endometrial biopsy is a precise method to diagnose the uterine cancer. However, patients with abnormal vaginal bleeding prior to the test may need a dilation and curettage (D&C) regardless of the finding of abnormal cells in the...
View full press release